Management of Erectile Dysfunction: An Under-recognition of Hypertension

被引:11
|
作者
Koroglu, Gokhan [1 ]
Kaya-Sezginer, Ecem [1 ]
Yilmaz-Oral, Didem [1 ,2 ]
Gur, Serap [1 ]
机构
[1] Ankara Univ, Dept Biochem & Pharmacol, Fac Pharm, Ankara, Turkey
[2] Cukurova Univ, Fac Pharm, Dept Pharmacol, Adana, Turkey
关键词
Antihypertensive treatment; endothelial dysfunction; erectile dysfunction; hypertension; phosphodiesterase-5; inhibitors; high blood pressure; QUALITY-OF-LIFE; NITRIC-OXIDE SYNTHASE; PENILE CORPUS CAVERNOSUM; CARDIOVASCULAR RISK-FACTORS; PROGENITOR CELLS CORRELATE; AMBULATORY BLOOD-PRESSURE; II RECEPTOR-BLOCKER; C-REACTIVE PROTEIN; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION;
D O I
10.2174/1381612824666180828104350
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Erectile dysfunction (ED) affects 30 million men in the US with a decrease in quality of life. Thirty percent of hypertensive men suffer from ED. Objective: This review will debate the interplay between hypertension and ED, discovering novel insights concerning hypertension-linked ED, as well as the influence of antihypertensive medications on patients with ED. Method: Total number of records screened from PubMed yielded by the search which performed from January 2000 - June 2018. Results: Hypertension can cause ED as a consequence of high blood pressure or antihypertensive treatment. Both hypertension and ED have endothelial dysfunction as a common base mechanism, which can lead to an increase in vascular smooth muscle contraction. Also, some phosphodiesterase (PDE)-5 inhibitors used to treat ED can recover blood pressure. Conclusion: Understanding of common mechanisms involved in ED accompanied with hypertension and the research on antihypertensive drugs that impact ED will bring important approaches for identifying novel therapeutic strategies that will improve quality of life in patients with these conditions.
引用
收藏
页码:3506 / 3519
页数:14
相关论文
共 50 条
  • [41] Pharmacotherapy for Erectile Dysfunction
    Eardley, Ian
    Donatucci, Craig
    Corbin, Jackie
    El-Meliegy, Amr
    Hatzimouratidis, Konstantinos
    McVary, Kevin
    Munarriz, Ricardo
    Lee, Sung Won
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (01) : 524 - 540
  • [42] Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient
    Jay Pravin Patel
    Eric Hweegeun Lee
    Carlos Ignacio Mena-Hurtado
    Charles N. Walker
    Current Cardiology Reports, 2017, 19
  • [43] The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function
    Maas, R
    Schwedhelm, E
    Albsmeier, J
    Böger, RH
    VASCULAR MEDICINE, 2002, 7 (03) : 213 - 225
  • [44] Pathophysiology of Erectile Dysfunction
    Matsui, Hotaka
    Sopko, Nikolai A.
    Hannan, Johanna L.
    Bivalacqua, Trinity J.
    CURRENT DRUG TARGETS, 2015, 16 (05) : 411 - 419
  • [45] Genetics of Erectile Dysfunction
    Lopushnyan, Natalya A.
    Chitaley, Kanchan
    JOURNAL OF UROLOGY, 2012, 188 (05) : 1676 - 1683
  • [46] Type 2 Diabetes Mellitus and Erectile Dysfunction
    Hidalgo-Tamola, Josephine
    Chitaley, Kanchan
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (04) : 916 - 926
  • [47] Understanding the erectile dysfunction-cardiovascular disease connection: clinical and pathophysiological insights
    An, Jinshun
    Xiang, Boyu
    Peng, Jingxuan
    Li, Dongjie
    SEXUAL MEDICINE REVIEWS, 2025,
  • [48] Emerging Role for TNF-α in Erectile Dysfunction
    Carneiro, Fernando S.
    Webb, Robert Clinton
    Tostes, Rita C.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (12) : 3823 - 3834
  • [49] Promising role of medicinal plants in the regulation and management of male erectile dysfunction
    Masuku, Nelisiwe Prenate
    Unuofin, Jeremiah Oshiomame
    Lebelo, Sogolo Lucky
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [50] The history of erectile dysfunction management
    Jonas, U
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2001, 13 (Suppl 3) : S3 - S7